Corrigendum to “Heteroatoms (B, N, S) doped quantum dots as potential drug delivery system for isoniazid: Insight from DFT, NCI, and QTAIM” [Heliyon Vol. 9, Iss. 1, January 2023, Article e12599] (Heliyon (2023) 9(1), (S2405844022038877), (10.1016/j.heliyon.2022.e12599))

Henry O. Edet, Hitler Louis, Terkumbur E. Gber, Precious S. Idante, Precious S. Idante, Thank God C. Egemonye, Providence B. Ashishie, Emmanuella E. Oyo-Ita, Innocent Benjamin, Adedapo S. Adeyinka

Research output: Contribution to journalComment/debate

Abstract

In the original published version of this article, there was an error in the structure of the compound “Isoniazid” depicted in the introduction section (Figure 1: Optimized structure of Isoniazid). Specifically, the structure was shown with an extra hydrogen atom (below).[Figure presented] This error has been rectified, with the figure updated to show the correct structure (below). Additionally, in section 3.6 reference [41] has been corrected to reference [38].[Figure presented] The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.

Original languageEnglish
Article numbere40199
JournalHeliyon
Volume10
Issue number23
DOIs
Publication statusPublished - 15 Dec 2024

ASJC Scopus subject areas

  • Multidisciplinary

Fingerprint

Dive into the research topics of 'Corrigendum to “Heteroatoms (B, N, S) doped quantum dots as potential drug delivery system for isoniazid: Insight from DFT, NCI, and QTAIM” [Heliyon Vol. 9, Iss. 1, January 2023, Article e12599] (Heliyon (2023) 9(1), (S2405844022038877), (10.1016/j.heliyon.2022.e12599))'. Together they form a unique fingerprint.

Cite this